AI @ HLTH: How Molecular You Identifies Diseases and Contextualizes Data
In this episode, Sandy Vance is speaking with Dr. Rob Fraser, founding CEO and current Chief Scientific Officer (CSO) and President, of Molecular You, a comprehensive AI-supported blood biomarker analysis platform. It empowers clinicians to harness the power of molecular medicine and artificial intelligence to maximize patient health outcomes. Molecular You uses AI tools to provide the most up-to-date and research-backed data to clinicians.
Episode Notes
Molecular You uses proteomics and metabolomics to measure and track over 250 biomarkers and generate risk profiles for more than 26 health conditions. By providing visibility into the underlying biochemical pathways that drive disease, clinicians can identify and treat dysfunction before it progresses to disease. In this conversation, Sandy Vance speaks with Dr. Rob Fraser about the potential of AI in disease identification and prevention; as well as its potential in extracting valuable research to provide doctors with detailed data. From comorbidity support to giving patients a more active role in their health, Molecular You is driving change in healthcare.
In this episode, they discuss:
How Molecular You identifies diseases at the earliest possible point to give patients access to early treatment
Successful use cases for Molecular You’s detection insights
How Molecular You supports women with early breast cancer identification
The research curation processes used by Molecular You, which use LLMs and automation
The patient benefits of Molecular You, and how it helps patients live longer and healthier lives
Fact-checking and cross-referencing systems Molecular You has created to verify LLM-extracted information
Molecular You delivers personalized lifestyle, diet, and supplement recommendations to support longevity, chronic disease management, and early disease prevention
How Molecular You uses AI tools to make sense of the data extracted from blood samples, and how they plan to continue implementing AI as the technology improves
A little about Dr. Fraser:
Rob was the founding CEO and is the current President and Chief Scientific Officer (CSO) of Molecular You Corporation. Backed by his expertise in molecular diagnostics, molecularly targeted drug discovery and development, biochemistry, and regulatory compliance, Rob Fraser drives the innovation behind Molecular You’s multi-biomarker analytics.
At Molecular You, Rob Fraser implemented a method of measuring hundreds of biomarkers from a single blood sample. This allows Molecular You to provide practitioners with detailed insights on patients, from early diagnoses to comorbidity support to diet personalization. Molecular You contextualizes this data establishing an LLM model, incorporating the world’s leading scientific literature.
